Sofinnova Ventures News Today

6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K ...

ASTRIA THERAPEUTICS, INC. 75 State Street, Suite 1400 Boston, MA 02109 NOTICE OF 2024 ANNUAL MEETING OF STOCKHOLDERS ...

Barry Selick, Ph.D., successful biopharmaceutical scientist, senior executive and entrepreneur, appointed Chief Executive Officer Carin Rollins, Hinge...

Hinge Bio Expands Senior Management Team to Drive GEM-DIMER™ Programs to Clinical Development - read this article along with other careers information, tips and advice on BioSpace

Ascendis Pharma (ASND) stock has lost nearly 40% of its value year to date. Check out why I think this sell-off in ASND stock is a buying opportunity.

In this article, we discuss the top 10 stock picks of Srini Akkaraju and Michael Dybbs Samsara BioCapital.

/PRNewswire/ -- Antiva Biosciences, a biopharmaceutical company developing novel, topical therapeutics for the treatment of pre-cancerous lesions caused by...

/PRNewswire/ -- Neurana Pharmaceuticals, a biotechnology company focused on the treatment of neuromuscular conditions, today announced the appointment of...

Neurana Pharmaceuticals to Present at 21st Annual Pain Therapeutics Conference News provided by Share this article Share this article SAN DIEGO, May 11, 2021 /PRNewswire/ -- Neurana Pharmaceuticals, a biotechnology company focused on the treatment of neuromuscular conditions, today announced that Randall Kaye, Chief Medical Officer, will present at the 21 st Annual Pain Therapeutics Conference. The conference takes place virtually May 10-11 th.  Presentations will be available for registered ...

(0) Novel mucoadhesive patch adheres to wet tissue surfaces and enables targeted, localized delivery of therapeutic to lesions inside the mouth AFYX Therapeutics ("AFYX"), a clinical stage biopharmaceutical company developing innovative approaches to treat mucosal diseases, today announced that a study of the Rivelin Clobetasol patch ("Rivelin-CLO"), a novel adhesive patch technology designed to deliver a therapeutic agent to wet tissue surfaces, was featured in the March issue of The Eur...